Modulation of cytotoxic drug activity by dipyridamole
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17, 57-65
- https://doi.org/10.1016/0305-7372(90)90017-a
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Dipyridamole Potentiates the Growth-Inhibitory Action of Methotrexate and 5-Fluorouracil in Human Keratinocytes In VitroJournal of Investigative Dermatology, 1989
- Multidrug Resistance: Molecular Biology Clinical RelevanceJNCI Journal of the National Cancer Institute, 1989
- Potentiation of Some Anticancer Agents by Dipyridamole against Drug-sensitive and Drug-resistant Cancer Cell LinesJapanese Journal of Cancer Research, 1989
- Enhancement of 5-fluorouracil's anticancer activity by dipyridamolePharmacology & Therapeutics, 1989
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988
- Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamoleBiochemical Pharmacology, 1987
- Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamoleBiochemical Pharmacology, 1986
- Relationship between leukemic cell retention of cytosine arabinoside triphosphate and the duration of remission in patients with acute non-lymphocytic leukemiaEuropean Journal of Cancer and Clinical Oncology, 1985
- Transport of nucleoside drugs in animal cellsPharmacology & Therapeutics, 1981
- Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexateBiochemistry, 1980